American Century Companies Inc. Raises Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
American Century Companies Inc. grew its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,015,728 shares of the company’s stock after purchasing an additional 88,882 shares during the period. American Century Companies […]
More Stories
Jefferies Financial Group Forecasts Strong Price Appreciation for Calibre Mining (TSE:CXB) Stock
Calibre Mining (TSE:CXB – Free Report) had its price objective lifted by Jefferies Financial Group from C$3.00 to C$3.50 in...
Sprott (TSE:SII) Price Target Raised to C$76.00
Sprott (TSE:SII – Free Report) had its price target hoisted by BMO Capital Markets from C$75.00 to C$76.00 in a...
Torex Gold Resources (TSE:TXG) Price Target Raised to C$45.00 at Royal Bank of Canada
Torex Gold Resources (TSE:TXG – Free Report) had its price objective raised by Royal Bank of Canada from C$44.00 to...
Hudbay Minerals (TSE:HBM) Price Target Raised to C$17.00 at Jefferies Financial Group
Hudbay Minerals (TSE:HBM – Free Report) (NYSE:HBM) had its price objective lifted by Jefferies Financial Group from C$14.00 to C$17.00...
OceanaGold (TSE:OGC) Stock Price Expected to Rise, Raymond James Analyst Says
OceanaGold (TSE:OGC – Free Report) had its price objective upped by Raymond James from C$5.50 to C$6.50 in a research...
Dollarama (TSE:DOL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says
Dollarama (TSE:DOL – Free Report) had its target price upped by Canaccord Genuity Group from C$146.00 to C$168.00 in a...